Currently Viewing:
Supplements Understanding Bipolar Disorder: Impact on Patients, Providers, and Empoyers
Bipolar Disorder: Disease Burden
Martha Sajatovic, MD
Bipolar Disorder and Work Loss
Charles L. Bowden, MD
Bipolar Disorder"Costs and Comorbidity
Robert M.A. Hirschfeld, MD; and Lana A. Vornik, MSc
Currently Reading
Participating Faculty

Participating Faculty

This supplement to The American Journal of Managed Care includes information on the burden of illness, costs and comorbidities, and work loss associated with bipolar disorder. This program has been peer reviewed by an expert in the field.

Faculty
Charles L. Bowden, MD
Professor of Psychiatry and Pharmacology
Department of Psychiatry
University of Texas Health Science Center at San Antonio
San Antonio, Texas

Robert M.A. Hirschfeld, MD
Titus H. Harris Chair
Professor and Chair
Department of Psychiatry and Behavioral Sciences
University of Texas Medical Branch
Galveston, Texas

Martha Sajatovic, MD
Associate Professor
Department of Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio

Lana A. Vornik, MSc
Senior Research Associate
Department of Psychiatry and Behavioral Sciences
University of Texas Medical Branch
Galveston, Texas

Faculty Disclosure

It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.

The following participants report relationships with pharmaceutical companies:

  • Charles L. Bowden, MD
      Research Grant From:
      • Bristol-Myers Squibb
      • Elan
      • National Institute of Mental Health
      • Parke-Davis
      • R.W. Johnson Pharmaceutical Institute
      • SmithKlineBeecham
      • Stanley Medical Research Foundation
      Speakers' Bureau For:
      • AstraZeneca
      • Pfizer
      Research Grant From, Consultant To, Speakers' Bureau For:
      • Abbott
      • GlaxoSmithKline
      • Janssen
      • Lilly Research
      Consultant To:
      • Sanofi-Synthelabo
      • UCB Pharma
  • Robert M.A. Hirschfeld, MD
      Consultant To and and/or Advisory Board For:
      • Abbott
      • AstraZeneca
      • Bristol-Myers Squibb
      • Eli Lilly
      • Forest
      • GlaxoSmithKline
      • Janssen
      • Novartis
      • Organon
      • Pfizer
      • Shire
      • UCB Pharma
      • Wyeth-Ayerst
  • Martha Sajatovic, MD
      Grant Research Support From:
      • Abbott
      • Bristol-Myers Squibb
      • Eli Lilly
      Consultant To:
      • AstraZeneca
      • Bristol-Myers Squibb
      • Eli Lilly
      • GlaxoSmithKline
      • Janssen
      Speaker' s Bureau For:
      • AstraZeneca
      • Bristol-Myers Squibb
      • Eli Lilly
      • Janssen
      • Pfizer

The following participant reports no relationships with any pharmaceutical company:

  • Lana A. Vornik, MSc

Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.

This program is being supported by an educational grant from AstraZeneca.

The contents of this supplement may include information regarding the use of products that may be inconsistent outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

PDF
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up